$SHL Telemedicine (SHLT.US)$ NEWS Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care SHL Telemedicine announces groundbreaking results from the Imperial College London TELE-ACS Trial, showing a 76% decrease in hospital readmissions and a 41% decrease in Emergency Department visits for post-MI patients. The trial demonstrated the effectiveness of SHL's SmartHeart® technology in remote cardiac care, with significant reduction...
SHL Telemedicine股票討論區
資訊
SHL Telemedicine透過在以色列推出革命性的在家生物標記血液測試,擴展了他們的遠程醫療解決方案。這項測試在SHL的醫療團隊的指導下,遵循12導聯心電圖,旨在迅速識別心臟病發作的心臟標記。結果在十分鐘內可得到。SHL將這項新的測試與病史和心電圖等內容整合起來…
SHL Telemedicine在以色列推出了一款革命性的在家生物標記血液測試,提升了他們的遠程醫療解決方案套件。這項測試在SHL的醫療團隊的指導下進行,通過12導聯心電圖,旨在快速識別心臟病發作的心臟標記。結果在十分鐘內可得到。SHL將這項新的測試與病史和心電圖等綜合…
NEWS
Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care
SHL Telemedicine announces groundbreaking results from the Imperial College London TELE-ACS Trial, showing a 76% decrease in hospital readmissions and a 41% decrease in Emergency Department visits for post-MI patients. The trial demonstrated the effectiveness of SHL's SmartHeart® technology in remote cardiac care, with significant reduction...
資訊
SHL的SmartHeart便攜式12導聯心電圖技術成功參與了美國陸軍的Project Convergence - Capstone 4實驗,展示出卓越的可靠性和使用友好性。該技術在極端場景下展示了其有效性,從而在非傳統環境中革新了緊急心血管評估。
暫無評論